For many people who want to conceive a baby, artificial insemination is the “first step” for anyone who is struggling to conceive via intercourse. Today, this procedure (known as intrauterine insemination, or IUI) is done in medical offices in a manner that is cost intensive, invasive, and unnecessarily complex to deliver.
Mosie Baby brings ease, privacy and dignity to this process by offering their customers an at home kit for artificial insemination. Mosie is the first syringe designed specifically for at-home insemination that’s safe, simple, affordable, patented, and clinically proven as effective as clinical insemination. Mosie customers have reported that 10,000+ babies have been born after using the kit. You can read a few of these stories here.
Led by a stellar team, Mosie Baby began as a D2C-first company, but in the last 12 months has seen rapid retail adoption. They are poised for a significant expansion in both CVS and Target and now marching towards clinical availability. Stay tuned for more on this company…and drop a line if you have connections or insights that make connecting with the company worthwhile.
More About RevUp Capital RevUp Capital invests in B2B and B2C companies that are revenue-driven and ready to double down on growth. We deploy cash and capacity to help companies grow from $1-3M to $10-30M, quickly and efficiently, using a revenue-based model. Companies enter our portfolio with $500K-$3M in revenue, a strong growth rate, and a team that’s ready to scale. Our typical investment range is $300K-$500K.
We invest into a company's market-facing activity using a cash and capacity model. We pair our cash investment with dedicated support from the RevUp Growth Platform: a powerful resource to build a data-driven growth engine, delivered by people who get the work done. Rather than take equity, companies return investment through a small percentage of revenue over time. More at www.revupfund.com)